- 2025,08,12
On the morning of August 11, ChengYi Pharmaceutical convened its first interim shareholders' meeting of 2025 at its manufacturing facility in Dongtou, Wenzhou, Zhejiang. The meeting utilized a combination of on-site and online voting to deliberate and vote on three proposals, including the "Employee Stock Ownership Plan." Chairman Yan Yiyi presided over the meeting, with senior executives such as General Manager Zhao Chunjian in attendance.
Since the beginning of the year, driven by national policies promoting the development of the marine economy and the revitalization of marine biomedicine, ChengYi Pharmaceutical's production and operational performance have shown continuous improvement, with the competitiveness of its core products steadily increasing. On July 13, the company released its 2025 first-half performance forecast, projecting a net profit attributable to shareholders of 107 million to 119 million yuan, a year-on-year increase of 40% to 55%. The adjusted net profit is expected to reach 106 million to 113 million yuan, representing a growth of 47.4% to 57.4%. The announcement indicated that the company's performance growth primarily stems from sustained sales increases in core joint-related medications, enhanced marketing efforts, and improved competitiveness of key products, thereby bolstering its first-half operational results. Benefiting from various policies and positive news, the company's stock attracted continuous inflows of institutional capital in August, securing three consecutive trading limits. As of the close on August 11, the stock price had surged by 111% in the first half of the year, drawing significant attention from the capital markets.
Against the backdrop of improving internal and external production and operational conditions, the company's board of directors resolved to formulate the "ChengYi Pharmaceutical Co., Ltd. 2025 Employee Stock Ownership Plan (Draft)" in accordance with the "Company Law," "Securities Law," and other relevant regulations. On July 13, the company announced documents such as the "Employee Stock Ownership Plan Management Measures" and scheduled an interim shareholders' meeting for August 11 to deliberate on the relevant proposals.
It is understood that the implementation of the "Employee Stock Ownership Plan" and related proposals will establish and improve a mechanism for shared interests between employees and shareholders, enhance corporate governance, increase employee cohesion and company competitiveness, motivate staff initiative and creativity, and promote the company's long-term, sustainable, and healthy development.
Source: Public Securities Journal